A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis-Reference-Cited by-同舟云学术

A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis

Published:2013-07-21 Issue:8 Volume:208 Page:1342-1348
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Castellanos-Gonzalez Alejandro,White A. Clinton,Ojo Kayode K.,Vidadala Rama S. R.,Zhang Zhongsheng,Reid Molly C.,Fox Anna M. W.,Keyloun Katelyn R.,Rivas Kasey,Irani Ayesha,Dann Sara M.,Fan Erkang,Maly Dustin J.,Van Voorhis Wesley C.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/208/8/1342/18069426/jit327.pdf

Reference21 articles.

1. Cryptosporidium species;White,2010

2. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study;Kotloff;Lancet,2013

3. Burden of disease from cryptosporidiosis;Shirley;Curr Opin Infect Dis,2012

4. Cryptosporidiosis;Lima,2011

5. Treatment of cryptosporidiosis: do we know what we think we know?;Cabada;Curr Opin Infect Dis,2010

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium;Molecular and Biochemical Parasitology;2024-12

2. E-pharmacophore and deep learning based high throughput virtual screening for identification of CDPK1 inhibitors of Cryptosporidium parvum;Computational Biology and Chemistry;2024-10

3. Understanding the Cryptosporidium species and their challenges to animal health and livestock species for informed development of new, specific treatment strategies;Frontiers in Parasitology;2024-08-06

4. Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A “One-Health” Concern;Life;2024-01-03

5. Identification of potent and orally efficacious phosphodiesterase inhibitors in sCryptosporidium parvum-infected immunocompromised mice;2023-09-26